• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡斯特曼病与系膜增生性肾小球肾炎:白细胞介素-6的作用

Castleman's disease and mesangial proliferative glomerulonephritis: the role of interleukin-6.

作者信息

Lui S L, Chan K W, Li F K, Cheng I K, Chan T M

机构信息

Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam.

出版信息

Nephron. 1998;78(3):323-7. doi: 10.1159/000044943.

DOI:10.1159/000044943
PMID:9546694
Abstract

Renal complications of Castleman's disease (angiofollicular lymph node hyperplasia) are uncommon. The reported cases are very heterogeneous and their renal pathology ranged from minimal change disease, mesangial proliferative glomerulonephritis, to amyloidosis. We have previously reported two cases of Castleman's disease with renal complications. We now present two more such cases. In contrast to other reports, all our cases are of the plasma cell type and their renal pathology showed remarkable similarities, namely mesangial proliferation, interstitial plasma cell infiltration and negative immunofluorescence. The level of serum interleukin-6 (IL-6) in both patients was elevated at presentation and came down with immunosuppressive therapy.

摘要

卡斯特曼病(血管滤泡性淋巴结增生)的肾脏并发症并不常见。报道的病例非常多样化,其肾脏病理表现从微小病变肾病、系膜增生性肾小球肾炎到淀粉样变性不等。我们之前曾报道过两例伴有肾脏并发症的卡斯特曼病病例。现在我们再介绍另外两例此类病例。与其他报道不同的是,我们所有的病例均为浆细胞型,其肾脏病理表现出显著的相似性,即系膜增生、间质浆细胞浸润以及免疫荧光阴性。两名患者就诊时血清白细胞介素-6(IL-6)水平均升高,免疫抑制治疗后下降。

相似文献

1
Castleman's disease and mesangial proliferative glomerulonephritis: the role of interleukin-6.卡斯特曼病与系膜增生性肾小球肾炎:白细胞介素-6的作用
Nephron. 1998;78(3):323-7. doi: 10.1159/000044943.
2
Successful treatment of a mesangial proliferative glomerulonephritis with interstitial nephritis associated with Castleman's disease by an anti-interleukin-6 receptor antibody (tocilizumab).通过抗白细胞介素-6受体抗体(托珠单抗)成功治疗伴有卡斯特曼病的系膜增生性肾小球肾炎合并间质性肾炎。
Intern Med. 2012;51(11):1375-8. doi: 10.2169/internalmedicine.51.6555. Epub 2012 Jun 1.
3
Membranoproliferative glomerulonephritis associated with multicentric angiofollicular lymph node hyperplasia. Case report and review of the literature.膜增生性肾小球肾炎合并多中心血管滤泡性淋巴结增生。病例报告及文献复习。
Am J Nephrol. 1992;12(6):466-70. doi: 10.1159/000168500.
4
Resolution of membranoproliferative glomerulonephritis complicating angiofollicular lymph node hyperplasia (Castleman's disease).血管滤泡性淋巴结增生(卡斯尔曼病)合并的膜增生性肾小球肾炎的缓解
Nephron. 1993;65(4):628-32. doi: 10.1159/000187576.
5
Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?与肾小球微血管病和MPGN样病变相关的多中心Castleman病:血管内皮细胞衍生生长因子在肾损伤中起致病作用还是保护作用?
Am J Kidney Dis. 2004 Jan;43(1):E3-9. doi: 10.1053/j.ajkd.2003.09.023.
6
Report of six kidney disease-associated Castleman's disease cases.6例与肾脏疾病相关的Castleman病病例报告。
Clin Nephrol. 2015 Dec;84(6):344-52. doi: 10.5414/CN108621.
7
Remission of nephrotic syndrome after thalidomide therapy in a patient with Castleman's disease.沙利度胺治疗Castleman病患者后肾病综合征缓解。
Clin Nephrol. 2004 May;61(5):352-6. doi: 10.5414/cnp61352.
8
Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum.与Castleman病相关的系统性反应性淀粉样变性:血清中急性期血清淀粉样蛋白A和白细胞介素6浓度的系列变化
J Clin Pathol. 1997 Nov;50(11):965-7. doi: 10.1136/jcp.50.11.965.
9
Castleman's disease in POEMS syndrome with elevated interleukin-6.伴有白细胞介素-6升高的POEMS综合征中的卡斯特曼病。
Cancer. 1992 Jun 1;69(11):2697-703. doi: 10.1002/1097-0142(19920601)69:11<2697::aid-cncr2820691112>3.0.co;2-3.
10
Membranoproliferative glomerulonephritis in the setting of multicentric angiofollicular lymph node hyperplasia (Castleman's disease) complicated by Evan's syndrome.多中心血管滤泡性淋巴结增生(Castleman 病)伴发膜增生性肾小球肾炎及 Evans 综合征。
J Clin Pathol. 2010 Jun;63(6):552-4. doi: 10.1136/jcp.2009.071415. Epub 2010 May 3.

引用本文的文献

1
Case report: Importance of early and continuous tocilizumab therapy in nephrotic syndrome associated with idiopathic multicentric Castleman disease: A case series.病例报告:托珠单抗早期持续治疗在特发性多中心Castleman病相关肾病综合征中的重要性:病例系列
Front Med (Lausanne). 2023 Jan 9;9:1037032. doi: 10.3389/fmed.2022.1037032. eCollection 2022.
2
Interleukin-6 receptor inhibition with tocilizumab in various renal involvements associated with multicentric Castleman's disease: a report of three cases.托珠单抗抑制白细胞介素-6受体治疗多中心Castleman病相关的各种肾脏受累:三例报告
NDT Plus. 2008 Dec;1(6):423-426. doi: 10.1093/ndtplus/sfn157. Epub 2008 Oct 8.
3
Efficacy of tocilizumab, a humanized neutralizing antibody against interleukin-6 receptor, in progressive renal injury associated with Castleman's disease.
托珠单抗(一种抗白细胞介素-6受体的人源化中和抗体)在与Castleman病相关的进行性肾损伤中的疗效。
CEN Case Rep. 2012 May;1(1):7-11. doi: 10.1007/s13730-012-0004-7. Epub 2012 Mar 17.
4
Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report.以不寻常的全身表现为特征的透明血管型多中心Castleman病:一例报告
J Med Case Rep. 2017 May 14;11(1):135. doi: 10.1186/s13256-017-1294-3.
5
Castleman's disease in childhood: report of three cases and review of the literature.儿童Castleman 病:三例报告并文献复习。
Ital J Pediatr. 2011 Oct 20;37:50. doi: 10.1186/1824-7288-37-50.
6
An autopsy case of multicentric Castleman's disease associated with interstitial nephritis and secondary AA amyloidosis.一例合并间质性肾炎和继发性AA型淀粉样变的多中心性Castleman病尸检病例。
Int J Hematol. 2008 Jan;87(1):69-74. doi: 10.1007/s12185-007-0015-x. Epub 2007 Dec 8.
7
Marked hepatomegaly due to AA type amyloidosis in a case with Castleman's disease.在一例Castleman病患者中,因AA型淀粉样变性导致明显肝肿大。
Int J Hematol. 2006 Jul;84(1):70-3. doi: 10.1532/IJH97.05126.
8
Treatment of Castleman's disease.卡斯尔曼病的治疗。
Curr Treat Options Oncol. 2005 May;6(3):255-66. doi: 10.1007/s11864-005-0008-z.